Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Sandra J. Lee
Based on 26 articles published since 2009
(Why 26 articles?)
||||
Expertise Level
The expertise of Sandra J. Lee ranks in the
  • Top 0.15%
  • ... of 106,334 published authors worldwide on Melanoma
  • ... from 2009 through 2019
  • ... based on contributions to 26 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Lee, Sandra J   ·   Lee, Sandra
Work Locations
Details
Most likely:    Harvard University Boston   Contact    
2019
  • Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. · University of Massachusetts Medical School, Worcester, Massachusetts. · Department of Dermatology, Stanford University Medical Center, Stanford University School of Medicine, Palo Alto, California. · Pigmented Lesion Clinic and Cutaneous Oncology Program, Department of Dermatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. Electronic address: · Pubmed 30654075
  • Department of Medicine, Brigham and Women's Hospital, Harvard Medical School. · Biostatistics and Computational Biology, Harvard School of Public Health. · Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York City, New York. · Department of Medicine, Tufts Medical School, Boston, Massachusetts. · Northwell Health Monter Cancer Center, Lake Success. · Departments of Medicine, Division of Hematology and Oncology. · Medicine, Cutaneous Oncology Multidisciplinary Program, Beth Israel Deaconess Medical Center. · Hematology and Oncology, Dana-Farber Cancer Institute. · Surgery. · Departments of Biostatistics and Computational Biology, Harvard Medical School. · Department of Medical Oncology, Georgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA. · Dermatology, Harvard Medical School. · Pubmed 30169431
2018
  • University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Novartis Pharmaceuticals, East Hanover, NJ, USA. · Vanderbilt University Medical Center, Nashville, TN, USA. · Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead NSW, Australia. · Genentech, San Francisco, CA, USA. · University of California Los Angeles Medical Center, Los Angeles, CA, USA. · Bristol-Myers Squibb, New York, NY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Northwestern University, Chicago, IL, USA. · University Hospital Essen and German Cancer Consortium, Essen, Germany. · Centre Hospitalo-Universitaire Timone, Aix Marseille University, Marseille, France. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead NSW, Australia. · Hillman University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA, USA. · Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, St Leonards, NSW, Australia. · Pubmed 29449192
2017
  • University of Pittsburgh, Pittsburgh, Pennsylvania. · Dana Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, Massachusetts. · University of Pittsburgh, Pittsburgh, Pennsylvania. · Seattle Cancer Care Alliance, Seattle, Washington. · Levine Cancer Institute, Carolinas Healthcare System, Charlotte, North Carolina. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Greater Baltimore Medical Center, Baltimore, Maryland. · Winship Cancer institute of Emory University, Atlanta, Georgia. · Pubmed 28536308
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Center for Immuno-oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. · Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. · Immunologic Monitoring and Cellular Products Laboratory, Hillman Cancer Center Research Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania. · Biomedical Research Laboratories, Medicine Faculty, Catholic University of Maule, Talca, Chile. · Novartis Institutes for BioMedical Research, Cambridge, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Pubmed 28522460
  • Columbia University Medical Center, New York, New York. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Massachusetts General Hospital, Boston, Massachusetts. · City of Hope, Duarte, California. · Memorial Sloan Kettering Cancer, New York, New York. · University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. · Case Western Reserve University, Cleveland, Ohio. · Hackensack Medical Center, Hackensack, New Jersey. · Saint Vincent Hospital, Green Bay, Wisconsin. · Greater Baltimore Medical Center, Baltimore, Maryland. · Rush University Medical Center, Chicago, Illinois. · University of Michigan Comprehensive Cancer Center. · Pubmed 28334439
  • Sanjiv S. Agarwala, Saint Luke's University Hospital, Easton · Uma N. Rao, Ahmad A. Tarhini, Terry L. Evans, and John M. Kirkwood, University of Pittsburgh Medical Center, Pittsburgh, PA · Sandra J. Lee, and Waiki Yip, Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA · Gary I. Cohen, Greater Baltimore Medical Center, Baltimore, MD · Douglas S. Reintgen, Lakeland Regional Cancer Center, Lakeland · Vernon K. Sondak, H. Lee Moffitt Cancer Center, Tampa, FL · Joanna M. Brell, MetroHealth Medical Center, Cleveland · William E. Carson, The Ohio State University Comprehensive Cancer Center, Columbus, OH · Mark R. Albertini, University of Wisconsin Hospital, Madison, WI · Michael B. Atkins, Georgetown Medical Center, Washington, DC · Shaker R. Dakhil, Cancer Center of Kansas, Wichita, KS · Robert M. Conry, University of Alabama at Birmingham, Birmingham, AL · Jeffrey A. Sosman, Vanderbilt University, Nashville · Alberto S. Pappo, Saint Jude Children's Research Hospital Oncology, Memphis, TN · Lawrence E. Flaherty, Wayne State University/Karmanos Cancer Institute, Detroit, MI · Michael G. Smylie, Cross Cancer Institute, Edmonton, Canada · and Richard F. Kefford, Sydney West Area Health Service, Westmead, Australia. · Pubmed 28135150
  • Department of Pediatrics and Microbiology/Immunology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. · Diabetes Center, UCSF, San Francisco, California, USA. · Center for Gastrointestinal Biology and Disease. · Department of Pathology and Laboratory Medicine, School of Medicine, and. · Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA. · Division of Hematology/Oncology, Department of Medicine, UCSF, San Francisco, California, USA. · Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, Massachusetts, USA. · Melanoma Committee, ECOG-ACRIN Cancer Research Group, and. · Melanoma and Skin Cancer Program, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA. · Division of Hematology/Oncology, Department of Medicine, School of Medicine, and. · Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. · Pubmed 28931755
  • Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California. · Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California. · Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania. · Dana-Farber Cancer Institute, Boston, Massachusetts. · ECOG-ACRIN Melanoma Committee, Philadelphia, Pennsylvania. · University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania. · Pubmed 28790109
2016
  • Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. · Dana Farber Cancer Institute, Boston, Massachusetts. · Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. · Departments of Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, Yale University School of Medicine, New Haven, Connecticut. · University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania. · Section of Medical Oncology, Yale Cancer Center, New Haven, Connecticut. · Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. · Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, Massachusetts. · Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. · Pubmed 26307133
  • Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. Electronic address: · Department of Dermatology, Pigmented Lesion and Melanoma Program, Stanford University Medical Center and Cancer Institute, Stanford, California, USA; Dermatology Service, VA Palo Alto Health Care System, Palo Alto, California, USA. · Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 27251792
2015
  • David H. Lawson, Winship Cancer Institute of Emory University, Atlanta, GA · Sandra Lee and Fengmin Zhao, Dana-Farber Cancer Institute · Michael B. Atkins, Beth Israel Deaconess Medical Center, Boston, MA · Ahmad A. Tarhini, Theresa L. Whiteside, Lisa H. Butterfield, and John M. Kirkwood, University of Pittsburgh Medical Center, Pittsburgh, PA · Kim A. Margolin, Seattle Cancer Care Alliance, Seattle, WA · Marc S. Ernstoff, Dartmouth-Hitchcock Medical Center, Lebanon, NH · and Gary I. Cohen, Greater Baltimore Medical Center, Baltimore, MD. · Pubmed 26351350
  • University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America. · University of Pittsburgh Cancer Institute Biostatistics Facility, Pittsburgh, Pennsylvania, United States of America. · Hellenic Cooperative Oncology Group, Athens, Greece. · Dana Farber Cancer Institute, Boston, Massachusetts, United States of America. · St. Luke's Cancer Center, Bethlehem, Pennsylvania, United States of America; Temple University, Philadelphia, Pennsylvania, United States of America. · Pubmed 26192408
2014
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts3Harvard Medical School, Harvard University, Boston, Massachusetts. · Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts5Harvard Medical School, Boston, Massachusetts. · University of Pittsburgh Department of Pathology, Pittsburgh, Pennsylvania. · University of Pittsburgh Department of Medicine, Pittsburgh, Pennsylvania. · Hematology and Oncology, The Christ Hospital Cancer Center, Cincinnati, Ohio9University of Cincinnati Department of Medicine, Cincinnati, Ohio. · Department of Medicine, Division of Hematology and Oncology, Vanderbilt University, Nashville, Tennessee. · Pubmed 25369488
  • Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy-Istituto Nazionale Tumori Fondazione "G Pascale", Napoli, Italy. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Gustave Roussy Cancer Campus, Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, University Hospital Kiel, Kiel, Germany. · Westmead Hospital and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Skin Cancer Program University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · Institute of Cancer Sciences, Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK. · Department of Internal Medicine 5-Hematology/Oncology, University of Erlangen, Erlangen, Germany. · Peter MacCallum Cancer Institute, St Andrews Place, East Melbourne, VIC, Australia. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Academic Unit of Oncology, University of Nottingham, Nottingham, UK. · Dermatology and INSERM Unit 981 Gustave Roussy Cancer Campus and Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Essen, Essen, Germany. Electronic address: · Pubmed 24485879
2014
  • Authors' Affiliations: Hematology/Oncology, Department of Medicine, University of Pennsylvania; Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania; Abramson Cancer Center of the University of Pennsylvania, Philadelphia; University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; Dana Farber Cancer Institute; Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, Massachusetts; Department of Pathology, Yale University School of Medicine; and Section of Medical Oncology, Yale Cancer Center, New Haven, Connecticut. · Authors' Affiliations: Hematology/Oncology, Department of Medicine, University of Pennsylvania; Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania; Abramson Cancer Center of the University of Pennsylvania, Philadelphia; University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; Dana Farber Cancer Institute; Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, Massachusetts; Department of Pathology, Yale University School of Medicine; and Section of Medical Oncology, Yale Cancer Center, New Haven, ConnecticutAuthors' Affiliations: Hematology/Oncology, Department of Medicine, University of Pennsylvania; Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania; Abramson Cancer Center of the University of Pennsylvania, Philadelphia; University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; Dana Farber Cancer Institute; Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, Massachusetts; Department of Pathology, Yale University School of Medicine; and Section of Medical Oncology, Yale Cancer Center, New Haven, Connecticut. · Authors' Affiliations: Hematology/Oncology, Department of Medicine, University of Pennsylvania; Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania; Abramson Cancer Center of the University of Pennsylvania, Philadelphia; University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; Dana Farber Cancer Institute; Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, Massachusetts; Department of Pathology, Yale University School of Medicine; and Section of Medical Oncology, Yale Cancer Center, New Haven, ConnecticutAuthors' Affiliations: Hematology/Oncology, Department of Medicine, University of Pennsylvania; Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania; Abramson Cancer Center of the University of Pennsylvania, Philadelphia; University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; Dana Farber Cancer Institute; Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, Massachusetts; Department of Pathology, Yale University School of Medicine; and Section of Medical Oncology, Yale Cancer Center, New Haven, Connecticut · Pubmed 24714776
2013
  • Authors' Affiliations: Gundersen Health System; Gundersen Medical Foundation, La Crosse, Wisconsin; Dana-Farber Cancer Institute, Boston, Massachusetts; University of Alabama Comprehensive Cancer Center, Birmingham, Alabama; and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania. · Pubmed 24122792
  • Massachusetts General Hospital, 55 Fruit St, Yawkey 9E, Boston, MA 02114, USA. · Pubmed 23248256
Probable:    Miscellaneous institutions in Philadelphia      
2017
  • Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California. · Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California. · Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania. · Dana-Farber Cancer Institute, Boston, Massachusetts. · ECOG-ACRIN Melanoma Committee, Philadelphia, Pennsylvania. · University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania. · Pubmed 28790109
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 26 total) written by Sandra J. Lee about Melanoma:

  • Clinicopathologic, misdiagnosis, and survival differences between clinically amelanotic melanomas and pigmented melanomas. 2019
  • Clinicopathologic features correlated with paradoxical outcomes in stage IIC versus IIIA melanoma patients. 2019
  • Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis. 2018
  • Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697). 2017
  • Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade. 2017
  • A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607). 2017
  • Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697). 2017
  • Combination central tolerance and peripheral checkpoint blockade unleashes antimelanoma immunity. 2017
  • Prospective Validation of Molecular Prognostic Markers in Cutaneous Melanoma: A Correlative Analysis of E1690. 2017
  • Copy Number Changes Are Associated with Response to Treatment with Carboplatin, Paclitaxel, and Sorafenib in Melanoma. 2016
Show List of Full Article Records
Google Searches

Learn more about Sandra J. Lee using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Harvard University Boston
Miscellaneous institutions in Philadelphia
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Harvard University Boston
2019
  • Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. · University of Massachusetts Medical School, Worcester, Massachusetts. · Department of Dermatology, Stanford University Medical Center, Stanford University School of Medicine, Palo Alto, California. · Pigmented Lesion Clinic and Cutaneous Oncology Program, Department of Dermatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. Electronic address: · Pubmed 30654075
  • Department of Medicine, Brigham and Women's Hospital, Harvard Medical School. · Biostatistics and Computational Biology, Harvard School of Public Health. · Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York City, New York. · Department of Medicine, Tufts Medical School, Boston, Massachusetts. · Northwell Health Monter Cancer Center, Lake Success. · Departments of Medicine, Division of Hematology and Oncology. · Medicine, Cutaneous Oncology Multidisciplinary Program, Beth Israel Deaconess Medical Center. · Hematology and Oncology, Dana-Farber Cancer Institute. · Surgery. · Departments of Biostatistics and Computational Biology, Harvard Medical School. · Department of Medical Oncology, Georgetown-Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA. · Dermatology, Harvard Medical School. · Pubmed 30169431
2018
  • University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Novartis Pharmaceuticals, East Hanover, NJ, USA. · Vanderbilt University Medical Center, Nashville, TN, USA. · Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead NSW, Australia. · Genentech, San Francisco, CA, USA. · University of California Los Angeles Medical Center, Los Angeles, CA, USA. · Bristol-Myers Squibb, New York, NY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Northwestern University, Chicago, IL, USA. · University Hospital Essen and German Cancer Consortium, Essen, Germany. · Centre Hospitalo-Universitaire Timone, Aix Marseille University, Marseille, France. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead NSW, Australia. · Hillman University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA, USA. · Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, St Leonards, NSW, Australia. · Pubmed 29449192
2017
  • University of Pittsburgh, Pittsburgh, Pennsylvania. · Dana Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, Massachusetts. · University of Pittsburgh, Pittsburgh, Pennsylvania. · Seattle Cancer Care Alliance, Seattle, Washington. · Levine Cancer Institute, Carolinas Healthcare System, Charlotte, North Carolina. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Greater Baltimore Medical Center, Baltimore, Maryland. · Winship Cancer institute of Emory University, Atlanta, Georgia. · Pubmed 28536308
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Center for Immuno-oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. · Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. · Immunologic Monitoring and Cellular Products Laboratory, Hillman Cancer Center Research Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania. · Biomedical Research Laboratories, Medicine Faculty, Catholic University of Maule, Talca, Chile. · Novartis Institutes for BioMedical Research, Cambridge, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. · Pubmed 28522460
  • Columbia University Medical Center, New York, New York. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Massachusetts General Hospital, Boston, Massachusetts. · City of Hope, Duarte, California. · Memorial Sloan Kettering Cancer, New York, New York. · University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. · Case Western Reserve University, Cleveland, Ohio. · Hackensack Medical Center, Hackensack, New Jersey. · Saint Vincent Hospital, Green Bay, Wisconsin. · Greater Baltimore Medical Center, Baltimore, Maryland. · Rush University Medical Center, Chicago, Illinois. · University of Michigan Comprehensive Cancer Center. · Pubmed 28334439
  • Sanjiv S. Agarwala, Saint Luke's University Hospital, Easton · Uma N. Rao, Ahmad A. Tarhini, Terry L. Evans, and John M. Kirkwood, University of Pittsburgh Medical Center, Pittsburgh, PA · Sandra J. Lee, and Waiki Yip, Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA · Gary I. Cohen, Greater Baltimore Medical Center, Baltimore, MD · Douglas S. Reintgen, Lakeland Regional Cancer Center, Lakeland · Vernon K. Sondak, H. Lee Moffitt Cancer Center, Tampa, FL · Joanna M. Brell, MetroHealth Medical Center, Cleveland · William E. Carson, The Ohio State University Comprehensive Cancer Center, Columbus, OH · Mark R. Albertini, University of Wisconsin Hospital, Madison, WI · Michael B. Atkins, Georgetown Medical Center, Washington, DC · Shaker R. Dakhil, Cancer Center of Kansas, Wichita, KS · Robert M. Conry, University of Alabama at Birmingham, Birmingham, AL · Jeffrey A. Sosman, Vanderbilt University, Nashville · Alberto S. Pappo, Saint Jude Children's Research Hospital Oncology, Memphis, TN · Lawrence E. Flaherty, Wayne State University/Karmanos Cancer Institute, Detroit, MI · Michael G. Smylie, Cross Cancer Institute, Edmonton, Canada · and Richard F. Kefford, Sydney West Area Health Service, Westmead, Australia. · Pubmed 28135150
  • Department of Pediatrics and Microbiology/Immunology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. · Diabetes Center, UCSF, San Francisco, California, USA. · Center for Gastrointestinal Biology and Disease. · Department of Pathology and Laboratory Medicine, School of Medicine, and. · Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA. · Division of Hematology/Oncology, Department of Medicine, UCSF, San Francisco, California, USA. · Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, Massachusetts, USA. · Melanoma Committee, ECOG-ACRIN Cancer Research Group, and. · Melanoma and Skin Cancer Program, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA. · Division of Hematology/Oncology, Department of Medicine, School of Medicine, and. · Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. · Pubmed 28931755
  • Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California. · Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California. · Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania. · Dana-Farber Cancer Institute, Boston, Massachusetts. · ECOG-ACRIN Melanoma Committee, Philadelphia, Pennsylvania. · University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania. · Pubmed 28790109
2016
  • Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. · Dana Farber Cancer Institute, Boston, Massachusetts. · Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. · Departments of Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, Yale University School of Medicine, New Haven, Connecticut. · University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania. · Section of Medical Oncology, Yale Cancer Center, New Haven, Connecticut. · Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. · Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, Massachusetts. · Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. · Pubmed 26307133
  • Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. Electronic address: · Department of Dermatology, Pigmented Lesion and Melanoma Program, Stanford University Medical Center and Cancer Institute, Stanford, California, USA; Dermatology Service, VA Palo Alto Health Care System, Palo Alto, California, USA. · Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 27251792
2015
  • David H. Lawson, Winship Cancer Institute of Emory University, Atlanta, GA · Sandra Lee and Fengmin Zhao, Dana-Farber Cancer Institute · Michael B. Atkins, Beth Israel Deaconess Medical Center, Boston, MA · Ahmad A. Tarhini, Theresa L. Whiteside, Lisa H. Butterfield, and John M. Kirkwood, University of Pittsburgh Medical Center, Pittsburgh, PA · Kim A. Margolin, Seattle Cancer Care Alliance, Seattle, WA · Marc S. Ernstoff, Dartmouth-Hitchcock Medical Center, Lebanon, NH · and Gary I. Cohen, Greater Baltimore Medical Center, Baltimore, MD. · Pubmed 26351350
  • University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America. · University of Pittsburgh Cancer Institute Biostatistics Facility, Pittsburgh, Pennsylvania, United States of America. · Hellenic Cooperative Oncology Group, Athens, Greece. · Dana Farber Cancer Institute, Boston, Massachusetts, United States of America. · St. Luke's Cancer Center, Bethlehem, Pennsylvania, United States of America; Temple University, Philadelphia, Pennsylvania, United States of America. · Pubmed 26192408
2014
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts3Harvard Medical School, Harvard University, Boston, Massachusetts. · Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts5Harvard Medical School, Boston, Massachusetts. · University of Pittsburgh Department of Pathology, Pittsburgh, Pennsylvania. · University of Pittsburgh Department of Medicine, Pittsburgh, Pennsylvania. · Hematology and Oncology, The Christ Hospital Cancer Center, Cincinnati, Ohio9University of Cincinnati Department of Medicine, Cincinnati, Ohio. · Department of Medicine, Division of Hematology and Oncology, Vanderbilt University, Nashville, Tennessee. · Pubmed 25369488
  • Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy-Istituto Nazionale Tumori Fondazione "G Pascale", Napoli, Italy. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Gustave Roussy Cancer Campus, Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, University Hospital Kiel, Kiel, Germany. · Westmead Hospital and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Skin Cancer Program University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · Institute of Cancer Sciences, Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK. · Department of Internal Medicine 5-Hematology/Oncology, University of Erlangen, Erlangen, Germany. · Peter MacCallum Cancer Institute, St Andrews Place, East Melbourne, VIC, Australia. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Academic Unit of Oncology, University of Nottingham, Nottingham, UK. · Dermatology and INSERM Unit 981 Gustave Roussy Cancer Campus and Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Essen, Essen, Germany. Electronic address: · Pubmed 24485879
2014
  • Authors' Affiliations: Hematology/Oncology, Department of Medicine, University of Pennsylvania; Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania; Abramson Cancer Center of the University of Pennsylvania, Philadelphia; University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; Dana Farber Cancer Institute; Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, Massachusetts; Department of Pathology, Yale University School of Medicine; and Section of Medical Oncology, Yale Cancer Center, New Haven, Connecticut. · Authors' Affiliations: Hematology/Oncology, Department of Medicine, University of Pennsylvania; Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania; Abramson Cancer Center of the University of Pennsylvania, Philadelphia; University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; Dana Farber Cancer Institute; Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, Massachusetts; Department of Pathology, Yale University School of Medicine; and Section of Medical Oncology, Yale Cancer Center, New Haven, ConnecticutAuthors' Affiliations: Hematology/Oncology, Department of Medicine, University of Pennsylvania; Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania; Abramson Cancer Center of the University of Pennsylvania, Philadelphia; University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; Dana Farber Cancer Institute; Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, Massachusetts; Department of Pathology, Yale University School of Medicine; and Section of Medical Oncology, Yale Cancer Center, New Haven, Connecticut. · Authors' Affiliations: Hematology/Oncology, Department of Medicine, University of Pennsylvania; Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania; Abramson Cancer Center of the University of Pennsylvania, Philadelphia; University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; Dana Farber Cancer Institute; Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, Massachusetts; Department of Pathology, Yale University School of Medicine; and Section of Medical Oncology, Yale Cancer Center, New Haven, ConnecticutAuthors' Affiliations: Hematology/Oncology, Department of Medicine, University of Pennsylvania; Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania; Abramson Cancer Center of the University of Pennsylvania, Philadelphia; University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; Dana Farber Cancer Institute; Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, Massachusetts; Department of Pathology, Yale University School of Medicine; and Section of Medical Oncology, Yale Cancer Center, New Haven, Connecticut · Pubmed 24714776
2013
  • Authors' Affiliations: Gundersen Health System; Gundersen Medical Foundation, La Crosse, Wisconsin; Dana-Farber Cancer Institute, Boston, Massachusetts; University of Alabama Comprehensive Cancer Center, Birmingham, Alabama; and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania. · Pubmed 24122792
  • Massachusetts General Hospital, 55 Fruit St, Yawkey 9E, Boston, MA 02114, USA. · Pubmed 23248256
Unspecified
2017
  • Department of Pediatrics and Microbiology/Immunology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. · Diabetes Center, UCSF, San Francisco, California, USA. · Center for Gastrointestinal Biology and Disease. · Department of Pathology and Laboratory Medicine, School of Medicine, and. · Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA. · Division of Hematology/Oncology, Department of Medicine, UCSF, San Francisco, California, USA. · Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, Massachusetts, USA. · Melanoma Committee, ECOG-ACRIN Cancer Research Group, and. · Melanoma and Skin Cancer Program, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA. · Division of Hematology/Oncology, Department of Medicine, School of Medicine, and. · Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. · Pubmed 28931755
Miscellaneous institutions in Philadelphia
2017
  • Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California. · Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California. · Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania. · Dana-Farber Cancer Institute, Boston, Massachusetts. · ECOG-ACRIN Melanoma Committee, Philadelphia, Pennsylvania. · University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania. · Pubmed 28790109
7 Other Locations Show
Yearly article counts 21622541012
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.